Combination of Gemcitabine and Erlotinib (GEM-ERLO) in Patients with Advanced Pancreatic Cancer or Advanced Cholangiocarcinoma: Clinical Outcome and Molecular Response Markers

Linardou, H. et al. (2008) Combination of Gemcitabine and Erlotinib (GEM-ERLO) in Patients with Advanced Pancreatic Cancer or Advanced Cholangiocarcinoma: Clinical Outcome and Molecular Response Markers. 14th Hellenic Conference of Clinical Oncology, Athens, Greece, 8-11 May 2008.

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Conference or Workshop Item
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kotronoulas, Dr Greg
Authors: Linardou, H., Murray, S., Kotronoulas, G., Papadopoulos, G., Economides, A., Arvanitakis, N., Kanaloupites, D., Pliarchopoulou, K., Bousboukea, E., Pavlidis, N., and Bafaloukos, D.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing > Nursing and Health Care

University Staff: Request a correction | Enlighten Editors: Update this record